What do we know about new cholesterol drug Lipfendra? Merck’s new once-daily drug gets FDA approval
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily cholesterol-lowering drug developed by Merck & Co. Lipfendra, whose generic name is enlicitide, works by blocking a protein called PCSK9. This protein typically reduces the liver’s ability to remove LDL cholesterol from the blood. (Representative)(UNSPLASH) The drug is the first oral drug … Read more
